Roots Analysis

Market Size

The global digital biomanufacturing market, valued at $2.4 billion in 2025, is projected to reach $2.8 billion in 2026 and $12.0 billion by 2035, representing a CAGR of 17.6% during the forecast period 2026 to 2035.

Global Digital Biomanufacturing Market 2022 to 2035

See What’s in the Full Report–Request Your Complimentary Insights!

Market Report: Key Takeaways

Market Size & Trends

In terms of type of technology, the manufacturing execution systems segment holds the highest share (nearly 35%) of the market.
With respect to deployment option, the on-premises segment is dominating the market with ~70% of the market share.
Based on the type of biologic manufactured, antibodies segment is dominating, and the cell and gene therapies segment is likely to grow at faster growth rate in the future.
Iin-house developers segment captures the majority of the market share (65%) in the current year, with respect to end user segment.
In terms of scale of operation, commercial sub-segment holds the largest share, and this trend is unlikely to change in the near future.
With respect to end user segment, humans segment captures the highest market share in the current year.
In terms of geographical regions, Europe is dominating the market by securing ~ 40% of the market share.

Key Market Statistics

Market Size in 2026: $2.8 Billion
Estimated Market Size in 2035: $12.0 Billion
CAGR (2026-2035): 17.6%
Europe: Largest market in 2026
Asia-Pacific: Fastest growing region

Market Overview

The production of biologics involves heavy investment for drug discovery, development and manufacturing. This can be attributed to the complex nature of these molecules, the need for specialized manufacturing facilities and stringent regulatory requirements. The rise in demand, coupled with the intricacies related to their manufacturing, has created immense pressure on the biopharmaceutical industry to reduce their production costs and timelines.

This has driven the need for automated end-to-end processes for manufacturing biologics, with the use of digital manufacturing solutions in the biopharmaceutical sector. This has compelled biopharmaceutical companies to shift from conventional manufacturing operations to digital biomanufacturing, led by the introduction of industry 4.0 technologies in the field of biomanufacturing.

Research suggests that around 20% of the organizations have already adopted digitalized approaches for manufacturing biologics. Such approaches are expected to ensure an uninterrupted and accessible supply of cost-effective drugs that are likely to be launched commercially, with reduced development timelines. In fact, several biopharmaceutical companies adopting digital biomanufacturing have claimed to achieve 40% increase in product quality, 15% reduction in cost, 80% decrease in process variability and 20% shorter operational timelines by leveraging digital biomanufacturing technologies.

Digital biomanufacturing, popularly known as bioprocessing 4.0, refers to the integration of physical equipment with digital technologies / software, such as process analytical technology (PAT), data analytical software (DAS) manufacturing execution systems (MES) and digital twins for biomanufacturing process control, developing biologics and streamline the overall biomanufacturing process. Total Lab Automation connects sample handling, analytical instruments and laboratory informatics within a coordinated workflow. Across related applications, continuous manufacturing systems integrate material handling, process control and quality monitoring into uninterrupted production lines.

Owing to the benefits offered by these digital technologies, many companies across various regions have adopted PAT in biomanufacturing, data analytics software for biomanufacturing process control, MES for developing biologics and digital twins. It is worth highlighting that implementation of digital technology is expected to revolutionize current digital biomanufacturing market and provide lucrative opportunities to the players offering digital biomanufacturing solutions for vaccine production and gene therapy production.

Recent Developments

In May 2026, Digital Tvilling announced a partnership to build an integrated AI-driven biomanufacturing platform focused on precision fermentation. The initiative aims to reduce production costs for proteins and food ingredients, with initial platform capabilities expected in 2026 and continuous learning from each fermentation cycle to improve efficiency.
In March 2026, Stämm introduced a high-throughput, automated bioprocessor designed for decentralized biomanufacturing, enabling scalable production of biologics and cell and gene therapies.
In March 2026, Bota launched SAION AI, a full-stack “Physical AI” platform for biomanufacturing that integrates cognition, orchestration, and execution layers. The system combines large language models with closed-loop experimentation to optimize biological discovery and manufacturing processes, representing a shift from in silico modeling to real-world automated and adaptive biomanufacturing systems.
In January 2026, Multiply Labs announced integration of NVIDIA’s digital twin, robotics simulation, and AI technologies to scale robotic biomanufacturing for cell and gene therapies. The collaboration leverages perception AI and foundation models to automate traditionally manual processes, aiming to improve throughput, reduce variability, and enable scalable production of advanced therapies in digitalized manufacturing environments.
In January 2026, WuXi Biologics launched PatroLab™, a digital twin platform combining real-time process monitoring, Raman-based analytics, and predictive modeling to enhance bioprocess development and manufacturing. The system enables proactive control, reduces risks, and shortens development timelines, supporting faster time-to-market and improved consistency in global biologics manufacturing operations.

Pay Only for What You Need–The Best Way to Optimize

Digital Biomanufacturing Market Trends

Several stakeholders have been forging alliances with other industry / non-industry players active in the market for different purposes, including technology integration, technology utilization, research and development, technology licensing and service alliances.
It is worth highlighting that since 2018, more than 125 strategic partnerships have been inked by technologies / software providers in the digital biomanufacturing industry.
Moreover, over 40% of the partnership agreements were inked in last two years; of these, technology integration emerged as the most popular type of partnership model. This indicates the substantial efforts of players towards enhancing their existing technology portfolios in this domain.

Industry Experts

The digital biomanufacturing market report features detailed transcripts of interviews held with the following industry stakeholders (arranged in decreasing order of seniority level):

Chief Executive Officer, Founder and President, Small Company, Canada
Former Chief Executive Officer and Managing Director, Small Company, Germany
Former Vice President of Operations and Strategic Initiatives, Mid-sized Company, US
Regional Sales Director, Asia-Pacific, and Quality and Manufacturing Digitization Specialist, Large Company, US
Former Director of Sales, Mid-sized, Israel
Business Consultant, Very Large Company, France

Market Share by Type of Technology

Currently, the MES market segment occupies majority of the share (33%) in overall digital biomanufacturing market. This can be attributed to the increasing adoption of manufacturing execution systems in biomanufacturing amongst mid-sized and large companies to achieve operational flexibility.
It is worth highlighting that integration of automated solutions such as manufacturing execution systems into bioproduction lines enables full access to real-time production data and better analysis of the manufacturing processes.
However, the process analytical technology segment is anticipated to grow at a relatively higher growth rate of 18.6%, during the given time period. This can be attributed to the ability of PAT systems in identifying and mitigating the risks associated with manufacturing at an early stage. A number of manufacturers are seeking expert opinion on how to implement process analytical technology in biomanufacturing.

Digital Biomanufacturing Market by Technology Type 2025

Market Share by Scale of Operation

In the current year, the market is dominated by the revenues generated from digital manufacturing of biologics at commercial scale, capturing around 90% of the market share. Further, owing to the likely approvals of various biologics in the late stage of development in the coming years, this trend is expected to remain the same during the forecast period.
The digital manufacturing market analysis suggests high CAGR of biologics at commercial scale (20%), during the forecast period.

Unlock Deeper Insights–Schedule Your Personalized Workshop Today!

Market Share by Type of Biologic Manufactured

Based on the type of biologic manufactured, the global digital biomanufacturing market is segmented into antibodies, peptides, cell and gene therapies, and other biologics. Currently, the market is dominated by antibodies being manufactured using digital technologies, capturing 70% of the market share. This can be attributed to the significant number of approved antibodies available in the market for treating various chronic disorders, which significantly contribute to overall revenues in the biomanufacturing industry.
The market for digitally manufactured cell and gene therapies is anticipated to grow at a relatively higher CAGR of 29%, during the given time period. This demonstrates the increased adoption of digitalization by industry players, for achieving operational excellence in the field of cell and gene therapy manufacturing.

Market Share by Deployment Option

As per digital biomanufacturing market forecast, in 2026, the market is anticipated to dominate by digital biomanufacturing technologies that are being deployed on-premises (67%). This can be attributed to a multitude of benefits offered by on-premises deployment, including enhanced data security, reduced privacy risks and increased operational flexibility within manufacturing facilities.
Cloud-based deployment is anticipated to grow at a relatively higher growth rate of 22%, during the given time period. This can be attributed to the fact that implementation of cloud software enables businesses to access software services remotely without huge investments in the infrastructure.

Digital Biomanufacturing Market by Deployment Option Type 2025

Market Share by End Users

Currently, the in-house developers segment occupies the highest market share (65%) of the overall market. This can be attributed to the fact that in-house developers have been actively adopting digital technologies as compared to contract manufacturers to achieve process automation, optimization, and end-to-end control of the manufacturing process.
The market for contract manufacturers is expected to grow at a relatively faster pace (20%), during the given time period. This can be attributed to the fact that the in-house developers are increasingly relying on contract manufacturers owing to limited in-house expertise and manufacturing capacity for biologics.

Market Share by Geographical Regions

According to our forecast, Europe is likely to capture the majority (~40%) share of the market, driven by the presence of several well-established players with extensive biomanufacturing capabilities in this region.
The detailed methodology across the global digital biomanufacturing market and revenue generated across various segments is available in the full report.

Want Information on Specific Region / Segment?

Key Market Insights

Key Advantages of Digital Biomanufacturing

Digital biomanufacturing allows real-time monitoring, data analytics, automation, modelling and process optimization, supporting the transformation of data into actionable insights. This allows biomanufacturers to develop a uniform process and reduce the variation in product quality across each batch, in order to achieve batch-to-batch consistencies.

Moreover, innovative technologies, such as AI and digital twins, have become an integral part of the manufacturing process development strategy, to future-proof their business operations and address various issues, including growing manufacturing expenses, stringent regulatory guidelines and deteriorating profit margins. Several companies have followed the best practices for healthcare digital twins, especially biomanufacturing, and have gained benefit.

Digital Biomanufacturing Market Concentration Analysis

Current Market Landscape of Digital Biomanufacturing

The current market landscape features the presence of more than 135 digital technologies / software, developed by various industry stakeholders to enable digitalization in the biomanufacturing industry. Notably, most of the technologies / software offered for the digital manufacturing of biologics are process analytical technologies (38%), followed by manufacturing execution systems (23%) and data analytical software (22%). Within this workflow, manufacturing execution system coordinates electronic batch records, materials, equipment and quality data on the production floor.

Further, it is worth mentioning that majority of manufacturing execution systems, data analytics software and process analytical technologies are capable of being deployed as cloud-based solutions (84%, 64% and 48%, respectively).

The digital biomanufacturing market landscape is fragmented, featuring the presence of over 100 companies offering different types of technologies for digital biomanufacturing. Overall, by company size, the market is dominated by small and mid-sized companies, which is indicative of the fact that this domain is currently evolving and offers opportunities for innovation and growth to the players emerging in this domain. Further, in terms of year of establishment, close to 55% of the companies were established before 2005, indicating the presence of well-established firms in digital biomanufacturing industry.

Have Questions? Let’s Get Them Answered

Market Size Analysis: Digital Biomanufacturing Market to Grow at 12% CAGR

The digital biomanufacturing market size is projected to reach $2.8 billion in the current year 2026. Driven by improved data analytics, better product yield, faster production timelines, access to real time operations and rising interest in paperless manufacturing amongst innovators, lucrative opportunities are expected to emerge for players offering bioprocessing 4.0 services. The market size is anticipated to grow to $12.0 billion by 2035, representing a CAGR of 17.6% during the forecast period.

Digital Biomanufacturing Market, Life Cycle Analysis of Industry

Market Segmentation Insights

Key Report Attributes	Details
Historical Trend	Since 2022
Forecast Period	Till 2035
Market Size 2026	$2.8 Billion
Market Size 2035	$12.0 Billion
CAGR (Till 2035)	~17.6%
Type of Technology	Manufacturing Execution Systems (MES) Process Analytical Technologies (PAT) Data Analytics Software (DAS) Digital Twins
Deployment Option	Cloud-based Deployment On-premises Deployment
Scale of Operation	Commercial Scale Clinical Scale
Type of Biologic Manufactured	Antibodies Peptides Cell and Gene Therapies Other Biologics
End Users	In-house Developers Contract Manufacturers Both End Users
Geographical Regions	North America (US and Canada) Europe (Germany, France, Italy, Spain, UK and Rest of the Europe) Asia-Pacific (China, India and Japan and Rest of Asia-Pacific) Middle East and North Africa (Saudi Arabia, United Arab Emirates and Egypt) Latin America (Brazil, Mexico and Argentina)
Key Players	Apprentice AspenTech CellPort Dassault Systèmes Eppendorf FUJIFILM Diosynth Biotechnologies GE Vernova Körber Merck Sartorius Siemens Striim Thermo Fisher Scientific Tridiagonal Software Vimachem (Full list of ~105 companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Market Landscape Technology Competitiveness Analysis Benchmarking Analysis Partnerships and Collaborations Market Sizing and Opportunity Analysis

SECTION I: REPORT OVERVIEW

+ 1. PREFACE

1.1. Introduction

1.2. Market Share Insights

1.3. Key Market Insights

1.4. Report Coverage

1.5. Key Questions Answered

1.6. Chapter Outlines

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations on the Industry

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross Border Dynamics

4.3. Conclusion

SECTION II: QUALITATIVE INSIGHTS

+ 5. EXECUTIVE SUMMARY

+ 6. INTRODUCTION

6.1. Chapter Overview

6.2. Overview of Digital Biomanufacturing in Healthcare

6.3. Emerging Technologies that Support Digital Biomanufacturing

6.3.1. Process Analytical Technology (PAT)

6.3.2. Data Analytics Software (DAS)

6.3.3. Bioprocess Digital Twins

6.3.4. Manufacturing Execution Systems (MES)

6.4. Challenges Associated with the Adoption of Digital Biomanufacturing

6.5. Future Perspectives

SECTION III: COMPETITIVE LANDSCAPE

+ 7. MARKET LANDSCAPE: PROCESS ANALYTICAL TECHNOLOGY

7.1. Chapter Overview

7.2. Process Analytical Technologies: Overall Market Landscape

7.2.1. Analysis by Deployment Option

7.2.2. Analysis by Technology Capability

7.3. Process Analytical Technologies: Providers Landscape

7.3.1. Analysis by Year of Establishment

7.3.2. Analysis by Company Size

7.3.3. Analysis by Location of Headquarters

7.3.4. Analysis by Number of Technologies Offered

7.3.5. Analysis by End Users

7.3.6. Analysis by Year of Establishment, Location of Headquarters and Technology Capability

7.3.7. Process Analytical Technologies: Competitive Analysis by Years of Experience, Location of Headquarters and Number of Technology Capabilities

+ 8. MARKET LANDSCAPE: DATA ANALYTICS SOFTWARE

8.1. Chapter Overview

8.2. Data Analytics Software: Overall Market Landscape

8.2.1. Analysis by Deployment Option

8.2.2. Analysis by Software Capability

8.3. Data Analytics Software: Providers Landscape

8.3.1. Analysis by Year of Establishment

8.3.2. Analysis by Company Size

8.3.3. Analysis by Location of Headquarters

8.3.4. Analysis by Number of Software Offered

8.3.5. Analysis by End Users

8.3.6. Analysis by Year of Establishment, Location of Headquarters and Software Capability

8.3.7. Data Analytics Software: Competitive Analysis by Years of Experience, Location of Headquarters and Number of Software Capabilities

+ 9. MARKET LANDSCAPE: MANUFACTURING EXECUTION SYSTEM

9.1. Chapter Overview

9.2. Manufacturing Execution Systems: Overall Market Landscape

9.2.1. Analysis by Deployment Option

9.2.2. Analysis by Technology Capability

9.2.3. Analysis by Integrated Software

9.2.4. Analysis by Regulatory Compliance

9.3. Manufacturing Execution Systems: Providers Landscape

9.3.1. Analysis by Year of Establishment

9.3.2. Analysis by Company Size

9.3.3. Analysis by Location of Headquarters

9.3.4. Analysis by Type of Service Offered

9.3.5. Manufacturing Execution Systems: Competitive Analysis by Years of Experience, Location of Headquarters and Number of Technology Capabilities

+ 10. MARKET LANDSCAPE: DIGITAL TWINS

10.1. Chapter Overview

10.2. Digital Twins: Overall Market Landscape

10.2.1. Analysis by Technology Capability

10.2.2. Analysis by Type of Twin

10.2.3. Analysis by Integrated Technology

10.3. Digital Twins: Providers Landscape

10.3.1. Analysis by Year of Establishment

10.3.2. Analysis by Company Size

10.3.3. Analysis by Location of Headquarters

10.3.4. Analysis by Number of Technologies Offered

10.3.5. Digital Twins: Competitive Analysis by Years of Experience, Location of Headquarters and Number of Technology Capabilities

11. DIGITAL BIOMANUFACTURING TECHNOLOGIES / SOFTWARE: COMPETITIVE ANALYSIS

11.1. Chapter Overview

11.2. Methodology

11.3. Digital Biomanufacturing Technologies / Software: Competitive Analysis

11.3.1. Process Analytical Technology

11.3.1.1. Assumptions and Key Parameters

11.3.1.2. Technology Competitiveness Analysis

11.3.2. Data Analytical Software

11.3.2.1. Assumptions and Key Parameters

11.3.2.2. Technology Competitiveness Analysis

11.3.3. Manufacturing Execution System

11.3.3.1. Assumptions and Key Parameters

11.3.3.2. Technology Competitiveness Analysis

11.3.4. Digital Twins

11.3.4.1. Assumptions and Key Parameters

11.3.4.2. Technology Competitiveness Analysis

+ 12. REGIONAL CAPABILITY ANALYSIS

12.1. Chapter Overview

12.2. Methodology and Key Assumptions

12.3. Regional Capability by Company Size and Region

12.3.1. Regional Capability of Small Players based in North America (Peer Group I)

12.3.2. Regional Capability of Mid-sized Players based in North America (Peer Group II)

12.3.3. Regional Capability of Large and Very Large Players based in North America (Peer Group III)

12.3.4. Regional Capability of Small Players based in Europe (Peer Group IV)

12.3.5. Regional Capability of Mid-sized Players based in Europe (Peer Group V)

12.3.6. Regional Capability of Large and Very Large Players based in Europe (Peer Group VI)

12.3.7. Regional Capability of Small and Mid-sized Players based in Asia-Pacific and Rest of the World (Peer Group VII)

12.3.8. Regional Capability of Very Large Players based in Asia-Pacific and Rest of the World (Peer Group VIII)

12.4. Regional Capability: Pockets of Innovation and White Spaces

SECTION IV: COMPANY PROFILES

+ 13. COMPANY PROFILES: LEADING PLAYERS OFFERING PROCESS ANALYTICAL TECHNOLOGY

13.1. Chapter Overview

13.2. AspenTech

13.2.1. Company Overview

13.2.2. Financial Information

13.2.3. Technology Portfolio

13.2.4. Recent Developments and Future Outlook

13.3. FUJIFILM Diosynth Biotechnologies

13.3.1. Company Overview

13.3.2. Financial Information

13.3.3. Technology Portfolio

13.3.4. Recent Developments and Future Outlook

13.4. Merck

13.4.1. Company Overview

13.4.2. Financial Information

13.4.3. Technology Portfolio

13.4.4. Recent Developments and Future Outlook

13.5. Thermo Fisher Scientific

13.5.1. Company Overview

13.5.2. Financial Information

13.5.3. Technology Portfolio

13.5.4. Recent Developments and Future Outlook

+ 14. COMPANY PROFILES: LEADING PLAYERS OFFERING DATA ANALYTICS SOFTWARE

14.1. Chapter Overview

14.2. Sartorius

14.2.1. Company Overview

14.2.2. Financial Information

14.2.3. Technology Portfolio

14.2.4. Recent Developments and Future Outlook

14.3. Eppendorf

14.3.1. Company Overview

14.3.2. Financial Information

14.3.3. Technology Portfolio

14.3.4. Recent Developments and Future Outlook

14.4. Striim

14.4.1. Company Overview

14.4.2. Technology Portfolio

14.5. Tridiagonal Software

14.5.1. Company Overview

14.5.2. Technology Portfolio

+ 15. COMPANY PROFILES: LEADING PLAYERS OFFERING DIGITAL TWINS

15.1. Chapter Overview

15.2. Dassault Systèmes

15.2.1. Company Overview

15.2.2. Financial Information

15.2.3. Technology Portfolio

15.2.4. Recent Developments and Future Outlook

15.3. Körber

15.3.1. Company Overview

15.3.2. Technology Portfolio

15.4. Siemens

15.4.1. Company Overview

15.4.2. Technology Portfolio

+ 16. COMPANY PROFILES: LEADING PLAYERS OFFERING MANUFACTURING EXECUTION SYSTEM

16.1. Chapter Overview

16.2. Apprentice

16.2.1. Company Overview

16.2.2. Financial Information

16.2.3. Technology Portfolio

16.2.4. Recent Developments and Future Outlook

16.3. CellPort

16.3.1. Company Overview

16.3.2. Technology Portfolio

16.4. GE Vernova

16.4.1. Company Overview

16.4.2. Technology Portfolio

16.5. Vimachem

16.5.1. Company Overview

16.5.2. Technology Portfolio

SECTION V: MARKET TRENDS

+ 17. PARTNERSHIPS AND COLLABORATIONS

17.1. Chapter Overview

17.2. Partnership Models

17.3. Digital Biomanufacturing: Partnerships and Collaborations

17.3.1. Analysis by Year of Partnership, Since 2018

17.3.2. Analysis by Type of Partnership

17.3.3. Analysis by Year and Type of Partnership, Since 2018

17.3.4. Analysis by Type of Technology

17.3.5. Analysis by Year of Partnership and Type of Technology, Since 2018

17.3.6. Analysis by Type of Partner

17.3.7. Most Active Players: Analysis by Number of Partnerships

17.3.8. Analysis by Geography

17.3.8.1. Local and International Agreements

17.3.8.2. Intracontinental and Intercontinental Agreements

+ 18. MARKET CONCENTRATION ANALYSIS

18.1. Chapter Overview

18.2. Assumptions and Key Parameters

18.3. Methodology

18.4. Market Concentration Analysis: Digital Biomanufacturing Providers

+ 19. INDUSTRY LIFECYCLE ANALYSIS

19.1. Chapter Overview

19.2. Overview of Industry Lifecycle

19.3. Digital Biomanufacturing: Historical Timeline of Key Events

19.4. Digital Biomanufacturing: Start-up Activity

19.5. Digital Biomanufacturing: Activity of Established Players

19.6. Digital Biomanufacturing: Partnership and Collaboration Trends

19.7. Digital Biomanufacturing: Funding and Investments Trends

19.8. Current Barriers to Wider Adoption of Digitalization in Biomanufacturing

19.9. Future Outlook of Digital Biomanufacturing

19.10. Industry Lifecycle Analysis: Digital Biomanufacturing

SECTION VI: MARKET OPPORTUNITY ANALYSIS

+ 20. GLOBAL DIGITAL BIOMANUFACTURING MARKET

20.1. Chapter Overview

20.2. Assumptions and Methodology

20.3. Global Digital Biomanufacturing Market: Historical Trends (2022-2024) and Forecasted Estimates (2025-2035)

20.3.1. Scenario Analysis

20.3.1.1. Conservative Scenario

20.3.1.2. Optimistic Scenario

20.4. Key Market Segmentations

+ 21. DIGITAL BIOMANUFACTURING MARKET, BY TYPE OF TECHNOLOGY

21.1. Chapter Overview

21.2. Key Assumptions and Methodology

21.3. Digital Biomanufacturing Market: Distribution by Type of Technology

21.3.1. Digital Biomanufacturing Market for MES: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

21.3.2. Digital Biomanufacturing Market for PAT Historical Trends (since 2022) and Forecasted Estimates (till 2035)

21.3.3. Digital Biomanufacturing Market for DAS: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

21.3.4. Digital Biomanufacturing Market for DT: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

21.4. Data Triangulation and Validation and Validation

+ 22. DIGITAL BIOMANUFACTURING MARKET, BY DEPLOYMENT OPTION

22.1. Chapter Overview

22.2. Key Assumptions and Methodology

22.3. Digital Biomanufacturing Market: Distribution by Deployment Option

22.3.1. Digital Biomanufacturing Market for On-premises Deployment: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

22.3.2. Digital Biomanufacturing Market for Cloud-based Deployment: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

22.4. Data Triangulation and Validation

+ 23. DIGITAL BIOMANUFACTURING MARKET, BY SCALE OF OPERATION

23.1. Chapter Overview

23.2. Key Assumptions and Methodology

23.3. Digital Biomanufacturing Market: Distribution by Type of Technology

23.3.1. Digital Biomanufacturing Market for Commercial Scale: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

23.3.2. Digital Biomanufacturing Market for Clinical Scale: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

23.4. Data Triangulation and Validation

+ 24. DIGITAL BIOMANUFACTURING MARKET, BY TYPE OF BIOLOGIC MANUFACTURED

24.1. Chapter Overview

24.2. Key Assumptions and Methodology

24.3. Digital Biomanufacturing Market: Distribution by Type of Biologic Manufactured

24.3.1. Digital Biomanufacturing Market for Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

24.3.2. Digital Biomanufacturing Market for Peptides: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

24.3.3. Digital Biomanufacturing Market for Cell and Gene Therapies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

24.3.4. Digital Biomanufacturing Market for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

24.4. Data Triangulation and Validation

+ 25. DIGITAL BIOMANUFACTURING MARKET, BY END USERS

25.1. Chapter Overview

25.2. Key Assumptions and Methodology

25.3. Digital Biomanufacturing Market: Distribution by End Users

25.3.1. Digital Biomanufacturing Market for In-house Developers: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

25.3.2. Digital Biomanufacturing Market for Contract Manufacturers: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

25.3.3. Digital Biomanufacturing Market for Both End Users: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

25.4. Data Triangulation and Validation

+ 26. DIGITAL BIOMANUFACTURING MARKET, BY GEOGRAPHICAL REGIONS

26.1. Chapter Overview

26.2. Key Assumptions and Methodology

26.3. Digital Biomanufacturing Market: Distribution by Key Geographical Regions

26.3.1. Digital Biomanufacturing Market in North America: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.1.1. Digital Biomanufacturing Market in the US: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.1.2. Digital Biomanufacturing Market in Canada: Historical Trends (2022-2024) and Forecasted Estimates (2025-2035)

26.3.2. Digital Biomanufacturing Market in Europe: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.2.1. Digital Biomanufacturing Market in Germany: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.2.2. Digital Biomanufacturing Market in France: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.2.3. Digital Biomanufacturing Market in Italy: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.2.4. Digital Biomanufacturing Market in Spain: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.2.5. Digital Biomanufacturing Market in the UK: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.2.6. Digital Biomanufacturing Market in Rest of Europe: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.3. Digital Biomanufacturing Market in Asia-Pacific: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.3.1. Digital Biomanufacturing Market in China: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.3.2. Digital Biomanufacturing Market in India: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.3.3. Digital Biomanufacturing in Rest of Asia-Pacific: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.4. Digital Biomanufacturing Market in Middle East and North Africa: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.4.1. Digital Biomanufacturing Market in Saudi Arabia: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.4.2. Digital Biomanufacturing Market in United Arab Emirates: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.4.3. Digital Biomanufacturing in Egypt: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.5. Digital Biomanufacturing Market in Latin America: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.5.1. Digital Biomanufacturing Market in Brazil: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.5.2. Digital Biomanufacturing Market in Mexico: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.3.5.3. Digital Biomanufacturing in Argentina: Historical Trends (since 2022) and Forecasted Estimates (till 2035)

26.4. Market Dynamics Assessment

26.4.1. Penetration Growth (P-G) Matrix

26.5. Data Triangulation and Validation

SECTION VII: OTHER EXCLUSIVE INSIGHTS

+ 27. CONCLUDING INSIGHTS

+ 28. EXECUTIVE INSIGHTS

SECTION VIII: APPENDICES

+ 29. APPENDIX I: TABULATED DATA

+ 30. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Key Market Segmentation

Figure 4.1 Lessons Learnt from Past Recessions

Figure 5.1 Executive Summary: Digital Biomanufacturing Landscape

Figure 5.2 Executive Summary: Market Trends

Figure 5.3 Executive Summary: Market Forecast and Opportunity Analysis

Figure 6.1 Overview of Digital Biomanufacturing in Healthcare

Figure 6.2 Software Capabilities of Digital Biomanufacturing Technologies

Figure 6.3 Challenges Associated with the Adoption of Digital Biomanufacturing

Figure 7.1 Digital Biomanufacturing Technologies: Distribution by Type of Technology

Figure 7.2 Process Analytical Technologies: Distribution by Deployment Option

Figure 7.3 Process Analytical Technologies: Distribution by Technology Capability

Figure 7.4 Process Analytical Technology Providers: Distribution by Year of Establishment

Figure 7.5 Process Analytical Technology Providers: Distribution by Company Size

Figure 7.6 Process Analytical Technology Providers: Distribution by Location of Headquarters (Region)

Figure 7.7 Process Analytical Technology Providers: Distribution by Location of Headquarters (Country)

Figure 7.8 Process Analytical Technology Providers: Distribution by Number of Technologies Offered

Figure 7.9 Process Analytical Technology Providers: Distribution by End Users

Figure 7.10 Process Analytical Technology Providers: Distribution by Year of Establishment, Location of Headquarters and Technology Capability

Figure 7.11 Process Analytical Technologies offered by Small Companies: Distribution by Years of Experience, Location of Headquarters and Number of Technology Capabilities

Figure 7.12 Process Analytical Technologies offered by Mid-sized Companies: Distribution by Years of Experience, Location of Headquarters and Number of Technology Capabilities

Figure 7.13 Process Analytical Technologies offered by Large Companies: Distribution by Years of Experience, Location of Headquarters and Number of Technology Capabilities

Figure 7.14 Process Analytical Technologies offered by Very Large Companies: Distribution by Years of Experience, Location of Headquarters and Number of Technology Capabilities

Figure 8.1 Data Analytics Software Providers: Distribution by Deployment Option

Figure 8.2 Data Analytics Software: Distribution by Software Capability

Figure 8.3 Data Analytics Software Providers: Distribution by Year of Establishment

Figure 8.4 Data Analytics Software Providers: Distribution by Company Size

Figure 8.5 Data Analytics Software Providers: Distribution by Location of Headquarters (Region)

Figure 8.6 Data Analytics Software Providers: Distribution by Location of Headquarters (Country)

Figure 8.7 Data Analytics Software Providers: Distribution by Number of Software Offered

Figure 8.8 Data Analytics Software Providers: Distribution by End Users

Figure 8.9 Data Analytics Software Providers: Distribution by Year of Establishment, Location of Headquarters and Software Capability

Figure 8.10 Data Analytics Software Providers: Distribution by Years of Experience, Location of Headquarters and Number of Software Capabilities

Figure 9.1 Manufacturing Execution Systems: Distribution by Deployment Option

Figure 9.2 Manufacturing Execution Systems: Distribution by Technology Capability

Figure 9.3 Manufacturing Execution Systems: Distribution by Integrated Software

Figure 9.4 Manufacturing Execution Systems: Distribution by Regulatory Compliance

Figure 9.5 Manufacturing Execution System Providers: Distribution by Year of Establishment

Figure 9.6 Manufacturing Execution System Providers: Distribution by Company Size

Figure 9.7 Manufacturing Execution System Providers: Distribution by Location of Headquarters (Region)

Figure 9.8 Manufacturing Execution System Providers: Distribution by Location of Headquarters (Country)

Figure 9.9 Manufacturing Execution System Providers: Distribution by Type of Service Offered

Figure 9.10 Manufacturing Execution Systems Offered by Small and Mid-sized Companies: Distribution by Years of Experience, Location of Headquarters and Number of Technology Capabilities

Figure 9.11 Manufacturing Execution Systems Offered by Large and Very Large Companies: Distribution by Years of Experience, Location of Headquarters and Number of Technology Capabilities

Figure 10.1 Digital Twins: Distribution by Technology Capability

Figure 10.2 Digital Twins: Distribution by Type of Twin

Figure 10.3 Digital Twins: Distribution by Integrated Technology

Figure 10.4 Digital Twins Providers: Distribution by Year of Establishment

Figure 10.5 Digital Twins Providers: Distribution by Company Size

Figure 10.6 Digital Twins Providers: Distribution by Location of Headquarters (Region)

Figure 10.7 Digital Twins Providers: Distribution by Location of Headquarters (Country)

Figure 10.8 Digital Twins Providers: Distribution by Number of Technologies Offered

Figure 10.9 Digital Twins Providers: Distribution by End Users

Figure 10.10 Digital Twins Providers: Distribution by Years of Experience, Location of Headquarters and Technology Capabilities

Figure 11.1 Competitive Analysis: Process Analytical Technologies for Digital Biomanufacturing

Figure 11.2 Competitive Analysis: Data Analytical Software for Digital Biomanufacturing

Figure 11.3 Competitive Analysis: Manufacturing Execution Systems for Digital Biomanufacturing

Figure 11.4 Competitive Analysis: Digital Twins for Digital Biomanufacturing

Figure 12.1 Regional Capability Analysis: Distribution by Location of Headquarters and Company Size

Figure 12.2 Regional Capability of Small Players based in North America (Peer Group I)

Figure 12.3 Regional Capability of Mid-sized Players based in North America (Peer Group II)

Figure 12.4 Regional Capability of Large and Very Large Players based in North America (Peer Group III)

Figure 12.5 Regional Capability of Small Players based in Europe (Peer Group IV)

Figure 12.6 Regional Capability of Mid-sized Players based in Europe (Peer Group V)

Figure 12.7 Regional Capability of Large and Very Large Players based in Europe (Peer Group VI)

Figure 12.8 Regional Capability of Small Players based in Asia-Pacific (Peer Group VII)

Figure 12.9 Regional Capability of Mid-sized Players based in Asia-Pacific (Peer Group VIII)

Figure 12.10 White Space Analysis: Distribution by Peer Groups and Type of Technology

Figure 13.1 AspenTech: Annual Revenues, FY 2021 onwards (USD Million)

Figure 13.2 FUJIFILM Diosynth Biotechnologies: Business Segment-wise Revenues, FY 2021 onwards (Billion Yen)

Figure 13.3 Merck: Business Segment-wise Revenues, FY 2021 onwards (EUR Billion)

Figure 13.4 Thermo Fisher Scientific: Business Segment-wise Revenues, FY 2021 onwards (USD Billion)

Figure 14.1 Sartorius: Business Segment-wise Revenues, FY 2022 onwards (EUR Billion)

Figure 14.2 Eppendorf: Business Segment-wise Revenues, FY 2021 onwards (EUR Million)

Figure 15.1 Dassault Systèmes: Annual Revenues, FY 2021 onwards (EUR Million)

Figure 17.1 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2018

Figure 17.2 Partnerships and Collaborations: Distribution by Type of Partnership

Figure 17.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2018

Figure 17.4 Partnerships and Collaborations: Distribution by Type of Technology

Figure 17.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Technology, Since 2018

Figure 17.6 Partnerships and Collaborations: Distribution by Type of Partner

Figure 17.7 Most Active Players: Distribution by Number of Partnerships

Figure 17.8 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements

Figure 17.9 Partnerships and Collaborations: International and Local Agreements

Figure 18.1 Market Concentration Analysis: Comparison of Key Offerings of Digital Biomanufacturing Providers

Figure 19.1 Digital Biomanufacturing: Historical Timeline of Key Events

Figure 19.2 Digital Biomanufacturing: Start-up Activity

Figure 19.3 Digital Biomanufacturing: Established Players Activity

Figure 19.4 Digital Biomanufacturing: Partnership and Collaborations-related Trends

Figure 19.5 Digital Biomanufacturing: Funding and Investment-related Trends

Figure 19.6 Digital Biomanufacturing: Future Outlook

Figure 19.7 Industry Lifecycle Analysis for Digital Biomanufacturing

Figure 20.1 Global Digital Biomanufacturing Market, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Billion)

Figure 20.2 Global Digital Biomanufacturing Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Billion)

Figure 20.3 Global Digital Biomanufacturing Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Billion)

Figure 21.1 Digital Biomanufacturing Market: Distribution by Type of Technology

Figure 21.2 Digital Biomanufacturing Market for MES: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 21.3 Digital Biomanufacturing Market for PAT: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 21.4 Digital Biomanufacturing Market for DAS: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 21.5 Digital Biomanufacturing Market for Digital Twins: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.1 Digital Biomanufacturing Market: Distribution by Deployment Option

Figure 22.2 Digital Biomanufacturing Market for On-premises Deployment: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.3 Digital Biomanufacturing Market for Cloud-based Deployment: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 23.1 Digital biomanufacturing market: Distribution by Scale of Operation

Figure 23.2 Digital Biomanufacturing Market for Commercial Scale: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 23.3 Digital Biomanufacturing Market for Clinical Scale: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 24.1 Digital Biomanufacturing Market: Distribution by Type of Biologic Manufactured

Figure 24.2 Digital Biomanufacturing Market for Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 24.3 Digital Biomanufacturing Market for Peptides: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 24.4 Digital Biomanufacturing Market for Cell and Gene Therapies: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 24.5 Digital Biomanufacturing Market for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 25.1 Digital Biomanufacturing Market: Distribution by End Users

Figure 25.2 Digital Biomanufacturing Market for In-house Developers: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 25.3 Digital Biomanufacturing Market for Contract Manufacturers: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 25.4 Digital Biomanufacturing Market for Both End Users: Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.1 Digital Biomanufacturing Market: Distribution by Geographical Regions

Figure 26.2 Digital Biomanufacturing Market in North America, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.3 Digital Biomanufacturing Market in the US, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.4 Digital Biomanufacturing Market in Canada, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.5 Digital Biomanufacturing Market in Europe, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.6 Digital Biomanufacturing Market in Germany Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.7 Digital Biomanufacturing Market in France, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.8 Digital Biomanufacturing Market in Italy, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.9 Digital Biomanufacturing Market in Spain, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.10 Digital Biomanufacturing Market in the UK, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.11 Digital Biomanufacturing Market in Rest of Europe, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.12 Digital Biomanufacturing Market in Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.13 Digital Biomanufacturing Market in China, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.14 Digital Biomanufacturing Market in India, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.15 Digital Biomanufacturing Market in Rest of Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.16 Digital Biomanufacturing Market in Middle East and North Africa, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.17 Digital Biomanufacturing Market in Saudi Arabia, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.18 Digital Biomanufacturing Market in United Arab Emirates, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.19 Digital Biomanufacturing Market in Egypt, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.20 Digital Biomanufacturing Market in Latin America, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.21 Digital Biomanufacturing Market in Brazil, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.22 Digital Biomanufacturing Market in Mexico, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.23 Digital Biomanufacturing Market in Argentina, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)

Figure 26.24 Penetration Growth (P-G) Matrix: Geographical Regions

Figure 26.25 Market Movement Analysis: Geographical Regions

Figure 27.1 Concluding Remarks: Digital Biomanufacturing Landscape

Figure 27.2 Concluding Remarks: Partnerships and Collaborations

Figure 27.3 Concluding Remarks: Market Forecast and Opportunity Analysis

+ List of Tables

Table 7.1 Process Analytical Technologies: Information on Technology Name, Technology Provider and Deployment Option

Table 7.2 Process Analytical Technologies: Information on Technology Capability

Table 7.3 Process Analytical Technologies: Information on Additional Technology Capability, Type of Biologic Manufactured and Regulatory Compliance

Table 7.4 Process Analytical Technology Providers: Information on Year of Establishment, Company Size, Location of Headquarters, Number of Technologies Offered and End Users

Table 8.1 Data Analytics Software: Information on Software Name, Software Provider and Deployment Option

Table 8.2 Data Analytics Software: Information on Software Capability

Table 8.3 Data Analytics Software: Information on Integrated Technology, Type of Biologic Manufactured and Regulatory Compliance

Table 8.4 Data Analytical Software Providers: Information on Year of Establishment, Company Size, Location of Headquarters, Number of Software Offered and End Users

Table 9.1 Manufacturing Execution Systems: Information on Technology Name, Technology Provider and Deployment Option

Table 9.2 Manufacturing Execution Systems: Information on Technology Capability and Integrated Software

Table 9.3 Manufacturing Execution Systems: Information on Regulatory Compliance

Table 9.4 Manufacturing Execution Systems: Information on Type of License and Type of Biologic Manufactured

Table 9.5 Manufacturing Execution System Providers: Information on Year of Establishment, Company Size, Location of Headquarters and Type of Service Offered

Table 10.1 Digital Twins: Information on Technology Capability

Table 10.2 Digital Twins: Information on Type of Twin and Integrated Technology

Table 10.3 Digital Twins Providers: Information on Year of Establishment, Company Size, Location of Headquarters, Number of Technologies Offered and End Users

Table 11.1 Competitive Analysis: Process Analytical Technologies for Digital Biomanufacturing

Table 11.2 Competitive Analysis: Data Analytics Software for Digital Biomanufacturing

Table 11.3 Competitive Analysis: Manufacturing Execution Systems for Digital Biomanufacturing

Table 11.4 Competitive Analysis: Digital Twins for Digital Biomanufacturing

Table 13.1 Process Analytical Technology Providers: List of Companies Profiled

Table 13.2 AspenTech: Company Snapshot

Table 13.3 AspenTech: Technology Capabilities

Table 13.4 AspenTech: Recent Developments and Future Outlook

Table 13.5 FUJIFILM Diosynth Biotechnologies: Company Snapshot

Table 13.6 FUJIFILM Diosynth Biotechnologies: Technology Capabilities

Table 13.7 FUJIFILM Diosynth Biotechnologies: Recent Developments and Future Outlook

Table 13.8 Merck: Company Snapshot

Table 13.9 Merck: Technology Capabilities

Table 13.10 Merck: Recent Developments and Future Outlook

Table 13.11 Thermo Fisher Scientific: Company Snapshot

Table 13.12 Thermo Fisher Scientific: Technology Capabilities

Table 13.13 Thermo Fisher Scientific: Recent Developments and Future Outlook

Table 14.1 Data Analytics Software Providers: List of Companies Profiled

Table 14.2 Sartorius: Company Snapshot

Table 14.3 Sartorius: Technology Portfolio

Table 14.4 Sartorius: Recent Developments and Future Outlook

Table 14.5 Eppendorf: Company Snapshot

Table 14.6 Eppendorf: Technology Portfolio

Table 14.7 Eppendorf: Recent Developments and Future Outlook

Table 14.8 Striim: Company Snapshot

Table 14.9 Striim: Technology Portfolio

Table 14.10 Tridiagonal Software: Company Snapshot

Table 14.11 Tridiagonal Software: Technology Portfolio

Table 15.1 Digital Twin Providers: List of Companies Profiled

Table 15.2 Dassault Systèmes: Company Snapshot

Table 15.3 Dassault Systèmes: Technology Portfolio

Table 15.4 Körber: Company Snapshot

Table 15.5 Körber: Technology Portfolio

Table 15.6 Siemens: Company Snapshot

Table 15.7 Siemens: Technology Portfolio

Table 16.1 Manufacturing Execution System Providers: List of Companies Profiled

Table 16.2 Apprentice: Company Snapshot

Table 16.3 Apprentice: Technology Portfolio

Table 16.4 CellPort: Company Snapshot

Table 16.5 CellPort: Technology Portfolio

Table 16.6 GE Vernova: Company Snapshot

Table 16.7 GE Vernova: Technology Portfolio

Table 16.8 Vimachem: Company Snapshot

Table 16.9 Vimachem: Technology Portfolio

Table 17.1 Digital Biomanufacturing Market: List of Partnerships and Collaborations, Since 2018

Table 17.2 Partnerships and Collaborations: Information on Type of Agreement

Table 18.1 Digital Biomanufacturing Providers: Information on Year of Entrance, Company Size, Type of Technology, Number of Technologies / Software Offered and Number of Partnerships Inked

Table 19.1 Overview of Industry Lifecycle Analysis

Table 19.2 Industry Lifecycle Analysis for Digital Biomanufacturing

Table 28.1 BioIntelligence Technologies: Company Snapshot

Table 28.2 Yokogawa Insilico Biotechnology: Company Snapshot

Table 28.3 Aizon: Company Snapshot

Table 28.4 MasterControl: Company Snapshot

Table 28.5 Trunovate: Company Snapshot

Table 28.6 Dassault Systèmes: Company Snapshot

Table 29.1 Digital Biomanufacturing Technologies: Distribution by Type of Technology

Table 29.2 Process Analytical Technologies: Distribution by Deployment Option

Table 29.3 Process Analytical Technologies: Distribution by Technology Capability

Table 29.4 Process Analytical Technology Providers: Distribution by Year of Establishment

Table 29.5 Process Analytical Technology Providers: Distribution by Company Size

Table 29.6 Process Analytical Technology Providers: Distribution by Location of Headquarters (Region)

Table 29.7 Process Analytical Technology Providers: Distribution by Location of Headquarters (Country)

Table 29.8 Process Analytical Technology Providers: Distribution by Number of Technologies Offered

Table 29.9 Process Analytical Technology Providers: Distribution by End Users

Table 29.10 Process Analytical Technologies: Distribution by Year of Establishment, Location of Headquarters and Technology Capability

Table 29.11 Data Analytics Software: Distribution by Deployment Option

Table 29.12 Data Analytics Software: Distribution by Software Capability

Table 29.13 Data Analytics Software Providers: Distribution by Year of Establishment

Table 29.14 Data Analytics Software Providers: Distribution by Company Size

Table 29.15 Data Analytics Software Providers: Distribution by Location of Headquarters (Region)

Table 29.16 Data Analytics Software Providers: Distribution by Location of Headquarters (Country)

Table 29.17 Data Analytics Software Providers: Distribution by Number of Software Offered

Table 29.18 Data Analytics Software Providers: Distribution by End Users

Table 29.19 Data Analytics Software Providers: Distribution by Year of Establishment, Location of Headquarters and Software Capability

Table 29.20 Manufacturing Execution Systems: Distribution by Deployment Option

Table 29.21 Manufacturing Execution Systems: Distribution by Technology Capability

Table 29.22 Manufacturing Execution Systems: Distribution by Integrated Software

Table 29.23 Manufacturing Execution Systems: Distribution by Regulatory Compliance

Table 29.24 Manufacturing Execution Systems Providers: Distribution by Year of Establishment

Table 29.25 Manufacturing Execution Systems Providers: Distribution by Company Size

Table 29.26 Manufacturing Execution Systems Providers: Distribution by Location of Headquarters (Region)

Table 29.27 Manufacturing Execution Systems Providers: Distribution by Location of Headquarters (Country)

Table 29.28 Manufacturing Execution Systems: Distribution by Type of Service Offered

Table 29.29 Digital Twins: Distribution by Technology Capability

Table 29.30 Digital Twins: Distribution by Type of Twin

Table 29.31 Digital Twins: Distribution by Integrated Technology

Table 29.32 Digital Twins Providers: Distribution by Year of Establishment

Table 29.33 Digital Twins Providers: Distribution by Company Size

Table 29.34 Digital Twins Providers: Distribution by Location of Headquarters (Region)

Table 29.35 Digital Twins Providers: Distribution by Location of Headquarters (Country)

Table 29.36 Digital Twins Providers: Distribution by Number of Technologies Offered

Table 29.37 Digital Twins Providers: Distribution by End Users

Table 29.38 AspenTech: Annual Revenues, FY 2021 onwards (USD Million)

Table 29.39 FUJIFILM Diosynth Biotechnologies: Business Segment-wise Revenues, FY 2021 onwards (Billion Yen)

Table 29.40 Merck: Business Segment-wise Revenues, FY 2021 onwards (EUR Billion)

Table 29.41 Thermo Fisher Scientific: Business Segment-wise Revenues, FY 2021 onwards (USD Billion)

Table 29.42 Sartorius: Business Segment-wise Revenues, FY 2022 onwards (EUR Billion)

Table 29.43 Eppendorf: Business Segment-wise Revenues, FY 2021 onwards (EUR Million)

Table 29.44 Dassault Systèmes: Annual Revenues, FY 2021 onwards (EUR Million)

Table 29.45 Regional Capability Analysis: Distribution by Location of Headquarters and Company Size

Table 29.46 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2018

Table 29.47 Partnerships and Collaborations: Distribution by Type of Partnership

Table 29.48 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2018

Table 29.49 Partnerships and Collaborations: Distribution by Type of Technology

Table 29.50 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Technology, Since 2018

Table 29.51 Partnerships and Collaborations: Distribution by Type of Partner

Table 29.52 Most Active Players: Distribution by Number of Partnerships

Table 29.53 Partnerships and Collaborations: Local and International Agreements

Table 29.54 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements

Table 29.55 Global Digital Biomanufacturing Market, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Billion)

Table 29.56 Global Digital Biomanufacturing Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Billion)

Table 29.57 Global Digital Biomanufacturing Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Billion)

Table 29.58 Digital Biomanufacturing Market: Distribution by Type of Technology

Table 29.59 Digital Biomanufacturing Market for MES: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.60 Digital Biomanufacturing Market for PAT: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.61 Digital Biomanufacturing Market for DAS: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.62 Digital Biomanufacturing Market for DT: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.63 Digital Biomanufacturing Market: Distribution by Deployment Option

Table 29.64 Digital Biomanufacturing Market for On-premises Deployment: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.65 Digital Biomanufacturing Market for Cloud-based Deployment: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.66 Digital Biomanufacturing Market: Distribution by Type of Biologic Manufactured

Table 29.67 Digital Biomanufacturing Market for Antibodies: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.68 Digital Biomanufacturing Market for Peptides: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.69 Digital Biomanufacturing Market for Cell and Gene Therapies: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.70 Digital Biomanufacturing Market for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.71 Digital Biomanufacturing Market: Distribution by End Users

Table 29.72 Digital Biomanufacturing Market for In-house Developers: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.73 Digital Biomanufacturing Market for Contract Manufacturers: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.74 Digital Biomanufacturing Market for Both End Users: Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.75 Digital Biomanufacturing Market: Distribution by Geographical Regions

Table 29.76 Digital Biomanufacturing Market in North America, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.77 Digital Biomanufacturing Market in the US, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.78 Digital Biomanufacturing Market in Canada, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.79 Digital Biomanufacturing Market in Europe, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.80 Digital Biomanufacturing Market in Germany Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.81 Digital Biomanufacturing Market in France, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.82 Digital Biomanufacturing Market in Italy, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.83 Digital Biomanufacturing Market in Spain, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.84 Digital Biomanufacturing Market in the UK, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.85 Digital Biomanufacturing Market in Rest of Europe, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.86 Digital Biomanufacturing Market in Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.87 Digital Biomanufacturing Market in China, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.88 Digital Biomanufacturing Market in India, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.89 Digital Biomanufacturing Market in Rest of Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.90 Digital Biomanufacturing Market in Middle East and North Africa, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.91 Digital Biomanufacturing Market in Saudi Arabia, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.92 Digital Biomanufacturing Market in United Arab Emirates, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.93 Digital Biomanufacturing Market in Egypt, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.94 Digital Biomanufacturing Market in Latin America, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.95 Digital Biomanufacturing Market in Brazil, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.96 Digital Biomanufacturing Market in Mexico, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

Table 29.97 Digital Biomanufacturing Market in Argentina, Historical Trends (since 2022) and Forecasted Estimates, Conservative, Base and Optimistic Scenarios (till 2035) (USD Million)

+ List of Companies and Organizations

Please reach out to our team for more details.

Digital Biomanufacturing Market